Skip to main content
GutCited

N-Acetyl Cysteine (NAC) 用于 Inflammatory Bowel Disease (IBD) — General

D

Pilot data only. Glutathione precursor may reduce oxidative stress in IBD. Requires larger clinical trials.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Dinflammatory\u002Dbowel\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

结论

Pilot data only. Glutathione precursor may reduce oxidative stress in IBD. Requires larger clinical trials.

Key Study Findings

Review
Nanocatalytic Antioxidation: A General Chemical Approach for Alleviating Oxidative Stress in Diseases.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Review of nanocatalytic antioxidation in diseases

Randomized Controlled Trial 16 weeks Open-label
Exploring the role of oxidative stress and the effect of N-acetylcysteine in thiopurine-induced liver injury …
Dose: N-acetylcysteine with thiopurine vs: Thiopurine alone (crossover) Outcome: Liver injury markers and oxidative stress 效果: None None

研究人群: IBD patients with thiopurine-induced liver injury

Review
The emerging role of oxidative stress in inflammatory bowel disease.
Dose: None vs: None Outcome: Oxidative stress role in IBD pathophysiology 效果: None None

研究人群: IBD patients (Crohn's and UC)

In Vitro 4.3 weeks
Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, and Kidney.
Dose: 150 mg/kg vs: None Outcome: inflammation markers 效果: None None

研究人群: Mice

Systematic Review 52 weeks
Vitamin D for the treatment of inflammatory bowel disease.
Dose: 400 IU/day vs: placebo Outcome: IBD disease activity 效果: None None

研究人群: Patients with IBD

Review
Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease …
Dose: None vs: None Outcome: Ferroptosis role in IBD pathogenesis 效果: None None

研究人群: IBD patients (mechanistic review)

Key Statistics

1

研究数量

30

受试者

Positive

D

等级

Referenced Papers

Frontiers in endocrinology 2024 165 次引用
Pharmaceuticals (Basel, Switzerland) 2023 18 次引用
The Cochrane database … 2023 1 次引用
European journal of … 2021 40 次引用
The British journal … 2012 145 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
600-1,200 mg/day in divided doses
hpyloriadjunct:
600 mg twice daily alongside standard triple therapy
antioxidantsupport:
600-900 mg/day

上限: Generally well-tolerated up to 1,800 mg/day; higher doses used in clinical settings

研究中使用的剂量

剂量 持续时间 效果 N
None -- Mixed --
N-acetylcysteine with thiopurine 16 weeks Positive --
None -- Positive --
150 mg/kg 4.3 weeks Positive --
400 IU/day 52 weeks Mixed --
None -- Neutral --
Various antioxidant compounds -- Positive --
None -- Mixed --

最佳服用时间: With or without food; divide doses throughout the day

Safety & Side Effects

已报告的副作用

  • Nausea and vomiting (most common, especially at higher doses)
  • Diarrhea
  • Unpleasant sulfur taste/odor
  • Headache

已知相互作用

  • Nitroglycerin (NAC may enhance vasodilatory effects; risk of hypotension)
  • Activated charcoal (may reduce NAC absorption)
  • Anticoagulants (NAC may have mild antiplatelet effects)
  • ACE inhibitors (additive hypotensive effect with nitroglycerin combination)

可耐受最高摄入量: Generally well-tolerated up to 1,800 mg/day; higher doses used in clinical settings

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does N-Acetyl Cysteine (NAC) help with Inflammatory Bowel Disease (IBD) — General?
Based on 1 studies with 30 participants, there is preliminary evidence that needs more research that N-Acetyl Cysteine (NAC) may support Inflammatory Bowel Disease (IBD) — General management. Our evidence grade is D (Very Early Research).
How much N-Acetyl Cysteine (NAC) should I take for Inflammatory Bowel Disease (IBD) — General?
Studies have used various dosages. A commonly studied range is 600-1,200 mg/day in divided doses. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of N-Acetyl Cysteine (NAC)?
Reported side effects may include Nausea and vomiting (most common, especially at higher doses), Diarrhea, Unpleasant sulfur taste/odor, Headache. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for N-Acetyl Cysteine (NAC) and Inflammatory Bowel Disease (IBD) — General?
We rate the evidence as Grade D (Very Early Research). This rating is based on 1 peer-reviewed studies with 30 total participants. The overall direction of effect is positive.

Related Evidence

其他成分用于 Inflammatory Bowel Disease (IBD) — General

N-Acetyl Cysteine (NAC) 用于其他健康状况

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。